Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Atropine on Pupil Size and Accommodation
NCT07674966Phase 1Completed
- Sponsor
- University of California, Berkeley
- Start
- Mar 2022
- Primary completion
- Oct 2022
- Countries
- 1
01
Overview
Phase 1 trial of NVK002 in myopia (3 arms), sponsored by University of California, Berkeley. Primary endpoint: Minimum pupil size. Started Mar 2022; status: completed.
02
Drugs
NVK002
03
Conditions
myopia
Beyond the preview
Go deeper on NCT07674966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07674966.